Cons Of Allergy Shots: Six Honest Downsides
Allergy shots carry six documented cons: a 3–5 year time commitment, approximately 39 in-clinic visits in year one with mandatory 30-minute observations, a 56.1% dropout rate before reaching maintenance (Tkacz 2021), a 16% local-reaction rate per injection, a 0.1% systemic-reaction rate, and a minimum $3,120 out-of-pocket cost over three years (Stachler 2020). The therapy works biologically when completed — but most US starters do not complete the course.
14 peer-reviewed sources
Six cons of allergy shots: multi-year time commitment, high in-office visit burden, documented 56.1% dropout before maintenance, 16% local reaction rate, 0.1% systemic reaction risk, and minimum $3,120 three-year out-of-pocket cost.
Honest downsides every prospective patient should weigh
Allergy shots are effective when completed — the Cochrane meta-analysis of 51 trials confirms symptom reduction, and the Durham 1999 NEJM study confirms durable post-treatment remission. But six structural cons determine whether a specific patient can actually access that benefit. These cons are real and quantified; they are not exaggerated. Characterizing them accurately is what enables a legitimate candidacy decision.
Before committing to a 3–5 year SCIT course, Curex at-home IgE testing with allergist review confirms the dominant sensitization — necessary because committing to the cons (time, visit burden, observation, local and systemic reaction risk) only makes sense when the immunotherapy plan correctly targets the allergen driving symptoms.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
What are the biggest cons of allergy shots?
The dominant cons are the visit burden (approximately 39 in-office visits in year one with mandatory 30-minute observation after each injection) and the documented dropout rate — only 43.9% of US starters reach maintenance and 23.9% never returned after their first injection per Tkacz et al. (Curr Med Res Opin 2021, n=103,207). Time commitment (3–5 years), local reactions (~16% per injection), systemic reaction risk (0.1% per visit), and cost ($3,120+ minimum OOP) are the other major cons.
How common are side effects from allergy shots?
Local injection-site reactions occur in approximately 16.3% of individual injections and affect about 78.3% of patients over the course of treatment (Calabria et al., JACI 2009, LOCAL study, n=9,678 injections). Systemic allergic reactions occur in approximately 0.1% of injection visits — most are mild (74% grade 1, urticaria and flushing). Grade 3 anaphylaxis represents about 3% of systemic reactions. Historical fatality rate is approximately 1 per 2.5 million injections.
Why do so many people quit allergy shots?
Real-world US data from 103,207 patients (Tkacz JP et al., Curr Med Res Opin 2021) found 56.1% of starters do not reach maintenance and 23.9% never returned after the first injection. The primary driver is the in-office visit burden — approximately 39 visits in year one, each requiring a 30-minute observation period. Work schedule conflicts, distance to clinic, and the slow timeline of noticeable benefit during the build-up phase are the most commonly cited adherence barriers.
Are allergy shots dangerous?
The systemic reaction risk is real but uncommon and has been stable across over 23 million injection visits in national surveillance (Epstein TG et al., JACIP 2014). At 0.1% per injection visit, systemic reactions — mostly mild urticaria or flushing — occur in about 1.9% of patients over a treatment course. Grade 3 anaphylaxis is about 0.003% of visits. Historical fatality rate is approximately 1 per 2.5 million injections, with one confirmed fatality documented across 23.3 million injection visits from 2008 to 2012. This risk is managed through mandatory observation and on-site epinephrine.
How much do allergy shots cost out of pocket?
Stachler (AAOA, December 2020) estimated a minimum of $3,120 out of pocket over three years at $20 per injection visit ($20 × 52 weeks × 3 years), rising to $6,240 for patients requiring two serums. At hospital outpatient departments (HOPDs), costs are substantially higher: PBS NewsHour documented a 2024 case with $24,400 total billed (M Health Fairview MN — Case 14), and KFF/NPR documented a 2018 Stanford case with $48,329 billed (Janet Winston — Case 16). Site of care is the largest cost variable.
Can you do allergy shots at home to avoid the visit burden?
Increasingly, yes — for eligible maintenance patients. Traditionally, subcutaneous immunotherapy was given only in-clinic because systemic reactions require immediate epinephrine access, and roughly 15% of systemic reactions have delayed onset beyond the 30-minute window, which is why clinics observe patients after each injection. Curex makes at-home self-administration safe for eligible maintenance patients with a specific safeguard stack: a serum sterile-compounded to USP <797> standards, a prescribed epinephrine auto-injector confirmed on hand before the first dose, the first dose and every dose change supervised live over Zoom by the prescribing physician, gradual week-by-week dose escalation, and board-certified allergist oversight — at $129/month. Patients who do not yet qualify, or who prefer the oral route, can discuss FDA-approved SLIT-tablets or off-label sublingual drops as alternatives.
Are allergy shots worth it despite the cons?
For the right patient — confirmed IgE sensitization, the capacity to sustain 3–5 years of treatment, and an allergen with strong RCT evidence — the documented benefits (Cochrane SMD −0.73, durable post-treatment remission, pediatric asthma prevention) outweigh the cons. For patients who cannot sustain the visit commitment, joining the 56.1% who do not complete the course means incurring most of the cons without capturing the full benefit. An honest candidacy assessment — accounting for schedule, allergen, and dropout risk — is the prerequisite to any worth-it conclusion.
What contraindications make allergy shots a bad choice?
Per AAAAI/ACAAI practice parameters (Cox 2011), allergy shots are contraindicated or require extreme caution in patients with poorly controlled asthma (FEV1 below 70% predicted), current beta-blocker use (blunts the epinephrine response used to treat anaphylaxis), ACE inhibitor use, unstable cardiovascular disease, untreated active malignancy, severe immunodeficiency, and at the initiation of pregnancy. These contraindications represent situations where the systemic reaction risk cannot be adequately managed.
Related Articles
Purpose of Allergy Shots: Mechanism & Clinical Intent
Allergy shots induce immune tolerance — IgE to IgG4. Three intents: symptom relief (Cochrane SMD −0.73), less medication, and durable disease modification.
Read moreAllergy Shots for Pollen: Who Qualifies | Curex Guide
Yes, allergy shots target pollen via SCIT. Cox 2011 candidacy threshold, FDA SLIT tablets, per-allergen efficacy, and Curex at-home shots — all covered.
Read moreAllergy Shots Effectiveness – RCT Evidence | Curex
Allergy shots effectiveness: Cochrane SMD −0.73 (51 RCTs, 2,871 patients). Per allergen: venom 95%+, grass 80%, cat 62%, Alternaria 63.5%. Real-world ceiling: 43.9% reach maintenance.
Read moreCat Allergy Vaccine Explained | Curex SCIT Guide
Cat allergy vaccine means three different things. SCIT uses FDA-standardized Fel d 1 extract for ~72% symptom relief. No one-shot cure exists.
Read moreSuccess Rate of Allergy Shots – Per Allergen | Curex
Success rate of allergy shots by allergen: venom >95%, grass ~80% medication reduction, cat ~62%, Alternaria 63.5% (yr 3). No single uniform percentage exists — here's the data.
Read moreDo Allergy Shots Work? Evidence & Honest Verdict | Curex
Do allergy shots work? Meta-analyses of 51 RCTs show 33-85% symptom reduction — but 20-50% of patients are low responders. Here's the honest evidence.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.